Document Detail

Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl.
MedLine Citation:
PMID:  21626048     Owner:  NLM     Status:  MEDLINE    
PURPOSE: The objective of this project was to systematically determine the prevalence and consequences of pulmonary fibrosis in youth with thyroid carcinoma and lung metastases from Belarus who were treated with radioiodine ((131)I).
METHODS: A total of 69 patients treated for juvenile thyroid carcinoma and lung metastasis with (131)I were assessed. A group of 29 patients without lung metastases and prior (131)I treatment served as controls. The assessments included a CT scan of the lungs, extensive pulmonary function testing and an incremental cycle test to volitional fatigue with measurements of oxygen uptake (VO(2)), oxygen saturation and alveolar-arterial difference in oxygen partial pressure (ΔaaO(2)).
RESULTS: Five patients with lung metastases showed advanced pulmonary fibrosis on CT scans and also had poorer lung functions compared with the 62 patients with none or minor signs of fibrosis and the 29 controls. Furthermore, these five patients showed lower peak VO(2), lower oxygen saturation at peak exercise and higher exercise ΔaaO(2). They were younger at the time of cancer diagnosis and had received chemotherapy more frequently than youth with pulmonary metastases who did not develop fibrosis. One of the five patients subsequently died from pulmonary fibrosis.
CONCLUSION: Following the Chernobyl catastrophe, about 7% of children treated with radioiodine for thyroid carcinoma and lung metastases displayed pulmonary fibrosis which was associated with functional impairments. Based on the characteristics of affected individuals, the number of radioiodine courses may have to be limited, especially in young children, and chemotherapy should be avoided.
Helge Hebestreit; Johannes Biko; Valentina Drozd; Yuri Demidchik; Antje Burkhardt; Andreas Trusen; Meinrad Beer; Christoph Reiners
Related Documents :
17670608 - Uniportal vats for mediastinal nodal diagnosis and staging.
23776338 - Long-term results of a randomized controlled trial evaluating preoperative chemotherapy...
21868518 - Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy...
16702938 - Long-term survival of askin tumor for 10 years with 2 relapses.
3575728 - Embolization in cataclysmal hemorrhage caused by squamous cell carcinomas of the head a...
20888308 - The application of current lifetable methods to compare cystic fibrosis median survival...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-05-28
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  38     ISSN:  1619-7089     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-08     Completed Date:  2011-11-28     Revised Date:  2012-02-14    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1683-90     Citation Subset:  IM    
University Children's Hospital, Josef-Schneider-Str. 2, 97080 Würzburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chernobyl Nuclear Accident*
Exercise Test
Iodine Radioisotopes / adverse effects,  therapeutic use
Lung Neoplasms / radiotherapy*,  secondary*
Lung Volume Measurements
Pulmonary Fibrosis / epidemiology*,  etiology*,  physiopathology,  radiography
Republic of Belarus / epidemiology
Risk Factors
Thyroid Neoplasms / pathology*,  radiotherapy*
Tomography, X-Ray Computed
Reg. No./Substance:
0/Iodine Radioisotopes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anaphylactic shock and lethal anaphylaxis caused by compound amino acid solution, a nutritional trea...
Next Document:  A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcino...